Author:
Filleau Christelle,Febvre-Richards Emma,Konig Alexandra,Fabre Roxane,Mouton Aurélie,Sacco Guillaume
Reference26 articles.
1. Troubles neurocognitifs d’origine frontale, interactions communicationnelles et maladie d’Alzheimer;Michalon;Rev Neurol,2018
2. Donepezil for mild cognitive impairment;Birks;Cochrane Database Syst Rev,2006
3. Haute Autorité de santé. Évaluation 2016 des médicaments Alzheimer–Intérêt médical insuffisant. 14 février 2017. www.has-sante.fr/jcms/pprd_2974197/fr/evaluation-2016-des-medicaments-alzheimer-interet-medical-insuffisant.
4. Cholinesterase inhibitors for patients with Alzheimer’s disease: systematic review of randomised clinical trials;Kaduszkiewicz;BMJ,2005
5. Potentially inappropriate prescribing including under-use amongst older patients with cognitive or psychiatric co-morbidities;Lang;Age Ageing,2010